Yaz manufacturer rakes in over $1 billion in profits in three months; Yaz sales continue decline

Bayer Corporation continues to rake in the profits. But at what cost?

Bayer Corporation had a 40% jump in second quarter profits from last year. The pharmaceutical giant made a whopping €747 million Euros ($1.07 billion!) in profits in the short time of April to July 2011, up from €530 million for the same period of time last year.

Sales of Yaz/Yasmin/Yaminelle continued to decline; however Bayer still had €505 million ($722) in Yaz sales in the first half of the 2011, down from €576 million in the first half of last year.

The numbers that our drug safety advocates would really like to see are how much Bayer made off of the thousands of women who were hospitalized because of Yaz, and now face permanent injuries.

The drug and medical device advocates for safety at Zoll, Kranz and Borgess ask this question every time they meet with the injured women they represent. Women who trusted their health and contraceptive needs to this company, but received a product that ultimately caused life-threatening conditions like deep vein thrombosis, stroke, gallbladder disease and pulmonary embolisms.

That product is Yaz birth control.

So Bayer releases their catchy, misleading Yaz commercials, the women buy it up and take the pills, and now they are stuck nursing injuries that will affect them for the rest of their lives.

If you are one of these women, you need information. Contact the drug and medical device advocates for safety at Zoll, Kranz and Borgess by contacting Anneke Kurt toll-free at 888.841.9623 or via email at Anneke@toledolaw.com. You can also visit our website by clicking here.